Januvia vs. Farxiga

See how Januvia and Farxiga compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Januvia only lowers blood sugar, while Farxiga is also approved for heart failure and chronic kidney disease.

  • Januvia is a flat once-daily dose with no titration, while Farxiga starts at 5 mg and can increase to 10 mg.

  • Januvia's most common side effects involve the respiratory tract, while Farxiga's involve urination and genital infections.

Januvia vs. Farxiga Drug Summary

Januvia

Januvia (sitagliptin) is a DPP-4 inhibitor used to lower blood sugar in adults with type 2 diabetes. It's taken as a single oral tablet once a day, with the dose set by kidney function rather than gradual titration. It's typically used alongside diet and exercise.

Farxiga

Farxiga (dapagliflozin) is an SGLT2 inhibitor that lowers blood sugar in adults and children 10 and older with type 2 diabetes. It's also approved to reduce heart failure hospitalization, treat heart failure directly, and slow chronic kidney disease. It's taken as one oral tablet daily, starting at 5 mg with an option to increase to 10 mg.

Januvia vs. Farxiga Side Effects

Januvia

Most common
Upper respiratory tract infection (up to 15.5%)
Nasopharyngitis (up to 11.0%)
Peripheral edema (up to 8.3%)
Headache (up to 5.5%)

Farxiga

Most common
Female genital mycotic infections (up to 6.9%)
Nasopharyngitis (up to 6.3%)
Urinary tract infections (up to 4.3%)
Back pain (up to 4.2%)

Januvia vs. Farxiga Dosage

Januvia

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 25 mg once daily At the start
Maximum dose 100 mg once daily If needed
Dose changes 2 increases As tolerated

Farxiga

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 5 mg once daily At the start
Maximum dose 10 mg once daily If needed
Dose changes 1 increase As tolerated

Januvia vs. Farxiga Indications

Januvia

Januvia is approved for one purpose: helping adults with type 2 diabetes manage blood sugar alongside diet and exercise. It doesn't carry approvals for heart or kidney conditions. It's not approved for type 1 diabetes or diabetic ketoacidosis.

  • Blood sugar control in adults with type 2 diabetes

  • Used as an add-on to diet and exercise

  • Often added after metformin isn't enough alone

  • Not approved for type 1 diabetes or ketoacidosis

Farxiga

Farxiga covers a broader range of approved uses than most oral diabetes drugs. Beyond blood sugar control in adults and kids 10 and up, it's approved for heart failure and to slow chronic kidney disease. It's not approved for type 1 diabetes or for treating existing diabetic ketoacidosis.

  • Blood sugar control in adults and kids 10+

  • Reduces heart failure hospitalization risk

  • Treats heart failure to cut cardiovascular death

  • Slows kidney function decline in chronic kidney disease

Januvia vs. Farxiga Pros and Cons

Januvia

Januvia offers a simple, weight-neutral option with a single flat dose and no boxed warning. Its tradeoff is a narrower approval: it only addresses blood sugar, not heart or kidney outcomes. Some patients experience joint pain or, rarely, pancreatitis.

Pros

  • No titration schedule, one steady dose

  • Weight-neutral compared to some other oral drugs

  • No boxed warning on the label

  • Lower risk of genital or urinary infections

Cons

  • Doesn't reduce heart failure or kidney disease risk

  • Dose must be adjusted for kidney function

  • Linked to severe joint pain in some patients

  • Rare risk of acute or necrotizing pancreatitis

Farxiga

Farxiga's clinical reach extends past blood sugar into heart failure and kidney protection, which matters for patients with those conditions. That breadth comes with genitourinary risks and a need for caution in kidney impairment. It also carries a rare but serious ketoacidosis warning.

Pros

  • Reduces heart failure hospitalization and death

  • Slows chronic kidney disease progression

  • Approved for children 10 and older

  • Only two dose strengths, simple to escalate

Cons

  • Higher risk of genital yeast infections

  • Rare risk of ketoacidosis even with normal glucose

  • Not recommended for significant kidney impairment

  • Can cause volume depletion or low blood pressure

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.